Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ascorbic acid
Drug ID BADD_D00171
Description A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
Indications and Usage Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.
Marketing Status approved; nutraceutical
ATC Code G01AD03; S01XA15
DrugBank ID DB00126
KEGG ID D00018
MeSH ID D001205
PubChem ID 54670067
TTD Drug ID D07AHW
NDC Product Code 63083-1505; 67157-101; 72783-1001; 63238-3000; 51552-0164; 49452-0742; 10695-126; 62512-0020; 51927-5098
UNII PQ6CK8PD0R
Synonyms Ascorbic Acid | Acid, Ascorbic | L-Ascorbic Acid | Acid, L-Ascorbic | L Ascorbic Acid | Vitamin C | Hybrin | Magnorbin | Sodium Ascorbate | Ascorbate, Sodium | Ascorbic Acid, Monosodium Salt | Ferrous Ascorbate | Ascorbate, Ferrous | Magnesium Ascorbate | Ascorbate, Magnesium | Magnesium di-L-Ascorbate | Magnesium di L Ascorbate | di-L-Ascorbate, Magnesium | Magnesium Ascorbicum
Chemical Information
Molecular Formula C6H8O6
CAS Registry Number 50-81-7
SMILES C(C(C1C(=C(C(=O)O1)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Prostate cancer metastatic21.04.02.004; 16.25.01.0020.000496%Not Available
Pruritus23.03.12.0010.001834%
Pulmonary embolism24.01.06.001; 22.06.02.0010.001735%Not Available
Pyrexia08.05.02.0030.003420%
Rash23.03.13.0010.002082%Not Available
Rash erythematous23.03.13.0290.000496%Not Available
Rash maculo-papular23.03.13.004--
Rash papular23.03.13.017--Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Renal failure20.01.03.0050.000991%Not Available
Renal pain20.02.03.0030.001338%Not Available
Respiratory failure22.02.06.002; 14.01.04.0030.000496%
Rhinorrhoea22.12.03.021--
Seizure17.12.03.0010.000991%
Shock24.06.02.002--Not Available
Skin cancer16.03.02.002; 23.08.02.002--Not Available
Sleep disorder19.02.04.0010.000496%Not Available
Somnolence19.02.05.003; 17.02.04.006--
Stomatitis07.05.06.005--
Suicide attempt19.12.01.0040.000496%
Swelling face08.01.03.100; 23.04.01.018; 10.01.05.018--Not Available
Swollen tongue07.14.02.003; 23.04.01.014; 10.01.05.015--Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.0070.000496%Not Available
Tenderness08.01.08.005--Not Available
Throat irritation22.12.03.029; 07.05.05.037--Not Available
Throat tightness22.12.03.031; 19.01.02.005--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombosis24.01.01.0060.000743%Not Available
Transient ischaemic attack24.04.06.005; 17.08.04.0010.000496%
The 5th Page    First    Pre   5 6 7    Next   Last    Total 7 Pages